INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 78 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $29,910,429 | -19.3% | 857,278 | +29.4% | 0.01% | -30.0% |
| Q3 2022 | $37,063,371 | +18.1% | 662,319 | +9.2% | 0.01% | +25.0% |
| Q2 2022 | $31,385,866 | -13.8% | 606,373 | +21.1% | 0.01% | 0.0% |
| Q1 2022 | $36,393,645 | -30.3% | 500,807 | +13.4% | 0.01% | -27.3% |
| Q4 2021 | $52,234,000 | -36.4% | 441,760 | -27.8% | 0.01% | -38.9% |
| Q3 2021 | $82,118,000 | +22.3% | 612,136 | +47.6% | 0.02% | +20.0% |
| Q2 2021 | $67,147,000 | +71.2% | 414,719 | -15.1% | 0.02% | +66.7% |
| Q1 2021 | $39,215,000 | +12349.2% | 488,636 | +3157.6% | 0.01% | – |
| Q2 2020 | $315,000 | -64.4% | 15,000 | -77.8% | 0.00% | – |
| Q4 2016 | $886,000 | – | 67,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |